Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: Houston TX, San Antonio TX, Nashville TN, Atlanta GA,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06095089
Phase 1, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Houston TX, San Antonio TX, Nashville TN, St Louis MO,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase 1, Recruiting
Multi-center MRD Registry for Inflammatory Breast Cancer
for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06966050
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04771520
Phase 2, Recruiting
Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
for
Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8,
Location: Houston TX, New Orleans LA
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07551596
Phase 2, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Houston TX, Dallas TX, Fort Worth TX, Memphis TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase 1, Phase 2, Recruiting
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
for
Obesity
Location: Webster TX, Dilworth MN, Lake Forest CA
Sponsor: Aconcagua Bio, Inc. a wholly owned subsidiary of Structure Therapeutics
Sex: All
Age: 25 - 70+
Code: NCT07815678
Phase 1, Phase 2, Recruiting
Effect of Materials for Subcuticular Suture (Quill vs. Monocryl) on Complications After Liver Resection
for
Liver and Intrahepatic Bile Duct Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04906174
Recruiting
Evaluating a Culinary Curriculum Program for Residents of Medication Assisted Therapy (MAT) Recovery Houses
for
Cooking Skills
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT07251205
Recruiting
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
for
Melanoma (Skin Cancer), Breast Cancer, Brain Metastasases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06545682
Phase 1, Recruiting
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
for
Diabetic Macular Edema (DME)
Location: Houston TX, The Woodlands TX, Austin TX, San Antonio TX,
Sponsor: BioAge Labs, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07812090
Phase 2, Recruiting
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder
for
Familial Platelet Disorder, Hematopoietic
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06261060
Phase 2, Recruiting
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Houston TX, Oklahoma City OK, Aurora CO, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06102902
Phase 1, Recruiting
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
for
Non-Small Cell Lung Cancer
Location: Houston TX, St. Petersburg FL, Fort Myers FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT05789082
Phase 1, Phase 2, Recruiting
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma
for
Cholangiocarcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05967182
Phase 2, Recruiting
Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Houston TX, New York NY
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT07408258
Phase 1, Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country